Postoperative radiation therapy for rectal cancer combined with UFT/leucovorin

ONCOLOGY

Volumn 14, Issue 10 SUPPL. 9, 2000, Pages 59-62

  Rosenthal, David I ^a   Haller, Daniel G ^b   Saltz, Leonard ^a   Semple, Deborah ^c,d   Minsky, Bruce D ^c,d  

^a Department of Radiation Oncology ^*

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 UFT PROTOCOL; 1-UFT PROTOCOL; ANTINEOPLASTIC AGENT; FOLINIC ACID; TEGAFUR; URACIL;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG COMBINATION; HUMAN; MULTIMODALITY CANCER THERAPY; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; RECTUM TUMOR;

ADMINISTRATION, ORAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; HUMANS; LEUCOVORIN; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; TEGAFUR; URACIL;

EID: 0034304657     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. NIH Consensus Conference: Adjuvant therapy for patients with colon and rectal cancer. JAMA 264:1444-1450, 1990.
2. Fisher B, Wolmark N, Rockette H, et al: Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP Protocol R-01. J Natl Cancer Inst 80:21-29, 1988.
3. Gastrointestinal Tumor Study Group: Survival after postoperative combination treatment of rectal cancer. N Engl J Med 315:1294-1295, 1986.
4. Krook JE, Moertel CG, Gunderson LL, et al: Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324:709-715, 1991.
5. O'Connell MJ, Martenson JA, Wieand HS, et al: Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery. N Engl Med 331:502-507, 1994.
6. Gastrointestinal Tumor Study Group: Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. J Clin Oncol 10:549-557, 1992.
7. Tepper J, O'Connell MJ, Petroni GR, et al: Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: Initial results of Intergroup 0144. J Clin Oncol 15:2030-2039, 1997.
8. Hill M, Norman A, Cunningham D, et al: Impact of protracted venous infusion fluorouracil with or without Interferon alfa-2a on tumor response, survival, and quality of life in advanced colorectal cancer. J Clin Oncol 13:2317-2323, 1995.
9. Findlay M, Van Cutsem E, Kocha W, et al: A randomized phase II study of Xeloda (capecitabine) in patients with advanced colorectal cancer (abstract). Proc Am Soc Clin Oncol 16:227a, 1997.
10. Baker S, Khor S, Adjej A, et al: Pharmacokinetic, oral bioavailability and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenase. J Clin Oncol 14:3085-3096, 1996.
11. Fujii S: BOF-A1 and BOF-A2: New 5-FU degradation inhibitory agents. Gan To Kagaku Ryoho 14:2244-2250, 1987.
12. Peters GJ, Van Groeningen CJ, Shomage JH, et al: Phase I clinical and pharmacokinetic study of S-1, an oral 5-fluorouracil (5-FU)-based antineoplastic agent (abstract 800). Proc Am Soc Clin Oncol 16:227a, 1997.
13. Fujii S, Ikenaka K, Fukushima M, et al: Effect of uracil and its derivative on antitumor activity of 5-fluorouracil 1-(2-tetrahydryofuryl)-5-fluorouracil. Gan 69:763-772, 1978.
14. Evans RM, Mech LV, Laskin JD, et al: Effects of excess folates and deoxyinosine on the activity and site of 5-fluorouracil. Cancer Res 41:3288-3295, 1981.
15. Petrelli N, Herrara L, Rustum Y, et al: A prospective randomized trial of 5-fluorouracil vs 5-fluorouracil and high-dose leucovorin vs 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. J Clin Oncol 5:1559-1565, 1987.
16. Petrelli N, Douglas HO, Herrara L, et al: The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma. A prospective randomized phase III trial. J Clin Oncol 7:1419-1426, 1989.
17. Taguchi T: Experience with UFT in Japan. Oncology 11:30-34, 1997.
18. Saltz L, Leichman C, Young C, et al: A fixed-ratio combination of uracil and Ftorafur (UFT) with low dose leucovorin. Cancer 75:782-785, 1995.
19. Pazdur R, Douillard J-Y, Skillings JR, et al: Multicenter phase III study of 5-fluorouracil (5-FU) or UFT in combination with leucovorin (LV) in patients with metastatic colorectal cancer (abstract). M. D. Anderson Cancer Center. Proc Am Soc Clin Oncol 263a:1009, 1999.
20. Carmichael J, Popiela T, Radstone D, et al: Randomized comparative study of Orzel (Oral Uracil/Tegafur [UFT] plus leucovorin [LV]) versus patenteral 5-fluorouracil (5-FU) plus LV in patients with metastatic colorectal cancer (abstract). Proc Am Soc Clin Oncol 264a:1015, 1999.
21. Hoff P, Janjan N, Skibber J, et al: Preoperative UFT/Leucovorin Therapy in Rectal Cancer. Oncology 14(suppl 9):56-58, 2000.
22. De La Torre A, Romos S, Valcarcel FJ, et al: Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer. Int J Radial Oncol Biol Phys 45:629-634, 1999.
23. Carney D: The pharmacology of intravenous and oral etoposide. Cancer 67:299-302, 1991.
24. Zhou X, Zhou-Pan X, Favre R, et al: Relative bioavailability of two oral formulations of Navelbine in cancer patients. Biopharm Drug Dispos 15:577-586, 1994.
25. Lee C, Nicholson P, Souhami R, et al: Patient compliance with prolonged low dose oral etoposide for small cell lung cancer. Br J Cancer 67:630-634, 1993.
26. Sadahiro S, Ohki S, Takahashi T, et al: Pilot study of the new dose intensive oral UFT schedule as adjuvant chemotherapy for colorectal cancer (abstract 1054). Proc Am Soc Clin Oncol 17:274a, 1998.
27. Lebovits AH, Strain JJ, Schleifer SJ, et al: Patient noncompliance with self-administered chemotherapy. Cancer 65:17-22, 1990.
28. Liu G, Franssen E, Fitch MI, Warner E: Patient preferences for oral vs intravenous palliative chemotherapy. J Clin Oncol 15:110-115, 1997.
29. Robert F, Raben D, Spencer S: UFT/Oral Calcium Folinate Plus Radiation in Pancreatic Cancer. Oncology 13(suppl 3):127-128, 1999.